Healthcare -
Medical - Healthcare Information Services - NASDAQ - SG
$ 3.7
-1.86 %
$ 137 M
Market Cap
-5.97
P/E
1. INTRINSIC VALUE
Balance Sheet
EUDA Health Holdings Limited
| Current Assets | 723 K |
| Cash & Short-Term Investments | 189 K |
| Receivables | 239 K |
| Other Current Assets | 295 K |
| Non-Current Assets | 587 K |
| Long-Term Investments | 0 |
| PP&E | 207 K |
| Other Non-Current Assets | 380 K |
| Current Liabilities | 8.72 M |
| Accounts Payable | 1.29 K |
| Short-Term Debt | 3.3 M |
| Other Current Liabilities | 5.42 M |
| Non-Current Liabilities | 75.1 K |
| Long-Term Debt | 75.1 K |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
EUDA Health Holdings Limited
| Revenue | 3.71 M |
| Cost Of Revenue | 2.86 M |
| Gross Profit | 842 K |
| Operating Expenses | 4.8 M |
| Operating Income | -3.96 M |
| Other Expenses | 4.48 M |
| Net Income | -8.44 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
EUDA Health Holdings Limited
| Net Income | -8.44 M |
| Depreciation & Amortization | 119 K |
| Capital Expenditures | -5 |
| Stock-Based Compensation | 0 |
| Change in Working Capital | 531 K |
| Others | 5.43 M |
| Free Cash Flow | -2.92 M |
Wall Street Analysts Price Targets
EUDA Health Holdings Limited
EUDA has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
EUDA does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
EUDA Health Holdings Limited
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
3 years ago
Nov 24, 2021
|
Bought
0 USD
|
Tan Meng Dong (James)
Director
|
+ 292250
|
0 USD |
7. News
EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation
- Preliminary Discussions Underway to Establish a Joint Venture
globenewswire.com
- 1 month ago
EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia
Singapore, May 08, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, proudly announces the successful completion of its acquisition of CK Health Plus Sdn Bhd (“CK Health”) today. This strategic move marks an expansion of EUDA's presence in Malaysia and underscores its commitment to revolutionizing the healthcare landscape in the region.
globenewswire.com
- 8 months ago
EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health
SINGAPORE, May 06, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it will acquire CK Health Plus Sdn Bhd (“CK Health”), a direct seller of holistic wellness consumer products in Malaysia.
globenewswire.com
- 8 months ago
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market's Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Nasdaq on January 9, 2024 indicating that the Company had failed to maintain a minimum market value of listed securities of $35 million over the previous 30 consecutive business days (the “MVLS Requirement”) as required by the Nasdaq Listing Rule 5550(b)(2).
globenewswire.com
- 1 year ago
EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on January 9, 2024 indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities (“MVLS”) of $35 million over the previous 30 consecutive business days as required by the Nasdaq Listing Rule 5550(b)(2).
globenewswire.com
- 1 year ago
EUDA Health Holdings Limited Enters into Letter of Intent for Proposed Merger with TheoremRx Inc.
SINGAPORE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering enhanced outcomes through personalized healthcare, today announced that it has signed a letter of intent dated October 4, 2023, with respect to the proposed merger with TheoremRx Inc. (“TheoremRx”), a private U.S.-based company focused on the development of new treatments with safe administration, low toxicity, and a high potential for polypharmacy usage to benefit patients suffering from cancer and women's health conditions.
globenewswire.com
- 1 year ago
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market's Continued Listing Requirements
Singapore, Sept. 22, 2023 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on August 10, 2023 indicating that the Company was not in compliance with the $1.00 Minimum Bid Price requirement set forth in the Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). On September 14, 2023, the Company received a written notice from Nasdaq stating that the closing bid price of the Company's common stock has been at $1.00 per share or greater for 10 consecutive business days from August 30 to September 13, 2023, and therefore the Company has regained compliance with the $1.00 Minimum Bid Price Requirement for continued listing on The Nasdaq Capital Market.
globenewswire.com
- 1 year ago
EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Requirement
Singapore, Aug. 14, 2023 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”).
globenewswire.com
- 1 year ago
EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
Singapore, Aug. 04, 2023 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”) received a notice (the “MVLS Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company's listed securities failed to comply with the $35 million market value of listed securities (“Market Value of Listed Securities”) requirement for continued listing on the Nasdaq Capital Market in accordance with Nasdaq Listing Rule 5550(b)(2) based upon the Company's Market Value of Listed Securities for the 30 consecutive business days prior to the date of the MVLS Notice.
globenewswire.com
- 1 year ago
8. Profile
Summary
EUDA Health Holdings Limited EUDA
COUNTRY
SG
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 137 M
Dividend Yield
0.00%
Description
EUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.
Contact
1 Pemimpin Drive, Singapore, 576151
https://euda.com
IPO
Date
Dec. 14, 2021
Employees
106
Officers
Ms. Jenifer Goh
President of Operations
Ms. Whye Shin Tay
Interim Chief Financial Officer
Mr. Alfred Lim
Executive Director
Dr. Wei Wen Chen
Chief Executive Officer & Director
Mr. Daniel Tan
Chief Technology Officer